A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses
-
Joke J. Apperloo
Abstract
An important number of patients dependent on renal dialysis prefer peritoneal dialysis to hemodialysis. In the case of peritoneal dialysis, the glucose polymer icodextrin is frequently added to the dialysis fluid as an osmotic agent, since this polymer is able to maintain an osmotic gradient across the peritoneal membrane longer than monomeric glucose, leading to a prolonged effective ultrafiltration time. It was previously shown that icodextrin is partly able to enter the blood via the lymphatic system, where hydrolysis to glucose oligomers such as maltose and maltotriose occurs. The presence of these oligomers in the blood appears to cause significant overestimations of the glucose values in several point-of-care (POC) glucose analyzers, with potentially dramatic consequences. This effect has been investigated for a series of POC glucose analyzers, both by analyzing the blood of peritoneal dialysis patients and by an in vitro investigation of the quantitative effects of maltose and maltotriose. In particular, POC analyzers utilizing the bacterially produced enzyme glucose dehydrogenase seem to lack glucose specificity.
References
1 King H, Aubert RE, Herman WH. Global burden of diabetes 1995–2025: prevalence, numerical estimates, and projections. Diabet Care 1998; 21: 1414–31. 10.2337/diacare.21.9.1414Search in Google Scholar PubMed
2 Riley SG, Chess J, Donovan KL, Williams JD. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid. Br Med J 2003; 327: 608–9. 10.1136/bmj.327.7415.608Search in Google Scholar PubMed PubMed Central
3 Oyibo SO, Pritchard GM, McLay L, James E, Laing I, Gokal R, et al. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med 2002; 19: 693–6. 10.1046/j.1464-5491.2002.00753.xSearch in Google Scholar PubMed
4 de Waart DR, Zweers MM, Struijk DG, Krediet RT. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21: 269–74. 10.1177/089686080102100307Search in Google Scholar
5 Mehmet S, Quan G, Thomas S, Goldsmith D. Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis. Diabet Med 2001; 18: 679–82. 10.1046/j.0742-3071.2001.00556.xSearch in Google Scholar PubMed
6 Wens R, Tamine M, Devriendt J, Collart F, Broeders N, Mestrez F, et al. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analysers. Perit Dial Int 1998; 18: 603–9. 10.1177/089686089801800608Search in Google Scholar
7 Janssen W, Harff G, Caers M, Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 1998; 44: 2379–80. 10.1093/clinchem/44.11.2379Search in Google Scholar
8 Davies DS. Kinetics of icodextrin. Perit Dial Int 1994; 14(Suppl 2): S45–50. 10.1177/089686089401402S07Search in Google Scholar
9 Wang R. Glucose monitoring for diabetic patients using icodextrin. Perit Dial Int 2004; 24: 296–7. 10.1177/089686080402400316Search in Google Scholar
©2005 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock
- Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells
- Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
- Assessment of iodine intake in mildly iodine-deficient pregnant women by a new automated kinetic urinary iodine determination method
- Butyrylcholinesterase activity and metabolic syndrome in obese patients
- The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study
- Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique
- Quality control in urinary stone analysis: results of 44 ring trials (1980–2001)
- External Quality Assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch “Calibration 2000” project
- Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy
- A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses
- Preanalytical variability in laboratory testing: influence of the blood drawing technique
- Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis
- Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment
- The number of consultant clinical chemists in the 15-nation European Union
- Biological variation of vascular endothelial growth factor
- Terminology, categories and representation of examinations in laboratory medicine
- Reply to W.G. Wood. Questionable results – who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073
- The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma
- 4th Conference on Hyperhomocysteinemia: Saarbrücken, Germany, April, 14–16, 2005, Saarland University
Articles in the same Issue
- Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock
- Conjugated linoleic acid suppresses the secretion of atherogenic lipoproteins from human HepG2 liver cells
- Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
- Assessment of iodine intake in mildly iodine-deficient pregnant women by a new automated kinetic urinary iodine determination method
- Butyrylcholinesterase activity and metabolic syndrome in obese patients
- The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study
- Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique
- Quality control in urinary stone analysis: results of 44 ring trials (1980–2001)
- External Quality Assessment in The Netherlands: time to introduce commutable survey specimens. Lessons from the Dutch “Calibration 2000” project
- Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy
- A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses
- Preanalytical variability in laboratory testing: influence of the blood drawing technique
- Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis
- Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment
- The number of consultant clinical chemists in the 15-nation European Union
- Biological variation of vascular endothelial growth factor
- Terminology, categories and representation of examinations in laboratory medicine
- Reply to W.G. Wood. Questionable results – who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073
- The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma
- 4th Conference on Hyperhomocysteinemia: Saarbrücken, Germany, April, 14–16, 2005, Saarland University
